计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| C107672-10mg |
10mg |
现货 ![]() |
| |
| C107672-50mg |
50mg |
期货 ![]() |
| |
| C107672-250mg |
250mg |
期货 ![]() |
| |
| C107672-1g |
1g |
期货 ![]() |
|
| 别名 | 南蛇藤素 | 10-羟基-2,4a,6a,9,12b,14a-六甲基-11-氧代-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14 b-十氢化-苉-2-羧酸 | 南蛇藤醇 | 苦瓜甙 | 苦瓜苷 | 苦瓜皂甙 | 苦瓜素 |
|---|---|
| 英文别名 | (2R,4aS,6aR,6aS,14aS,14bR)-10-hydroxy-2,4a,6a,6a,9,14a-hexamethyl-11-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylicacid | IDI1_000718 | MLS002701906 | US9694016, 1156 | NCGC00178913-14 | Spectrum4_001966 | BSPBio_001905 | KBio2_003383 | CHEBI:63959 |
| 规格或纯度 | Moligand™, ≥98% |
| 英文名称 | Celastrol |
| 生化机理 | Celastrol (Tripterin) 是一种源自植物的三萜类化合物。Celastrol(Tripterin) 具有抗炎和免疫抑制活性。Celastrol(Tripterin) 是一种抗氧化剂和抗炎剂。能有效抑制线粒体中的脂质过氧化反应,抑制 TNF-α 诱导的 NFκB 激活。还能在体外抑制拓扑异构酶 II 的活性(IC50 = 7.41 μM),具有抗炎和抗增殖作用(IC50 = 2.12 µM)。能够调节多种细胞信号通路(抑制 NF-κB、上调细胞质 HSP70 和 HSP27、抑制 VEGF/Akt/mTOR 通路、抑制 TNF-α、蛋白酶体抑制剂)。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 备注 | 如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。有毒,请参阅SDS以获取更多信息。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 |
| 产品介绍 |
存在于卫矛科植物雷公藤、南蛇藤等中的抗癌活性成分。该化合物结构载于2006年5月份Cancer Research杂志封面,并证实南蛇藤素通过抑制蛋白酶体活性进而诱发癌细胞凋亡,是有效的蛋白酶体抑制剂,其显著抑制了裸鼠身上前列腺癌的增生。因此,在癌症的预防和治疗方面,南蛇藤素是具有巨大开发潜力的天然蛋白酶体抑制剂。雷公藤红素是一种强力抗氧化,抗发炎剂。它是一种新型的HSP90的抑制剂(扰乱Hsp90/Cdc37复合物),抗癌(抗血管生成 - 抑制VEGFR的表达);抗氧化剂(抑制脂质过氧化反应)和抗发炎活性(抑制iNOS及炎性细胞因子的生产)。 Celastrol, Celastrus scandens, a compound originally purified from Tripterygium wilfordii, has been shown to be an anti-peroxidative and anti-angiogenic agent. Mechanistic studies suggest that Celastrol suppresses levels of VEGF and Flk-1 receptors, VEGFR-1 and VEGFR-2, which may reduce signal transduction between the two growth factors. Additionally, Celastrol has demonstrated the ability to disrupt critical interaction of Glu33 (Hsp90) and Arg167 (Cdc37) in the superchaperone complex which causes anti-proliferative activity in vitro and inhibit Topo II (topoisomerase II) activity in vitro (IC50 = 7.41 μM). Celastrol, Celastrus scandens is an inhibitor of Hsp90. |
| 纯度 | ≥98% |
| PubChem SID | 504756877 |
|---|---|
| EC号 | 636-472-5 |
| 分子类型 | 小分子 |
| IIUPAC Name | (2R,4aS,6aR,6aS,14aS,14bR)-10-hydroxy-2,4a,6a,6a,9,14a-hexamethyl-11-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylic acid |
| INCHI | 1S/C29H38O4/c1-17-18-7-8-21-27(4,19(18)15-20(30)23(17)31)12-14-29(6)22-16-26(3,24(32)33)10-9-25(22,2)11-13-28(21,29)5/h7-8,15,22,31H,9-14,16H2,1-6H3,(H,32,33)/t22-,25-,26-,27+,28-,29+/m1/s1 |
| InChi Key | KQJSQWZMSAGSHN-JJWQIEBTSA-N |
| Smiles | CC1=C(C(=O)C=C2C1=CC=C3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C)O |
| Isomeric SMILES | CC1=C(C(=O)C=C2C1=CC=C3[C@]2(CC[C@@]4([C@@]3(CC[C@@]5([C@H]4C[C@](CC5)(C)C(=O)O)C)C)C)C)O |
| 关联CAS | 34157-83-0 |
| NSC Number | 70931 |
| UN Number | 2811 |
| MeSH Entry Terms | 3-hydroxy-24-nor-2-oxo-1(10),3,5,7-friedelatetraen-29-oic acid;celastrol;tripterin;tripterine |
| 分子量 | 450.61 |
| Reaxy-Rn | 5780870 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=5780870&ln= |
| 溶解性 | Soluble in DMSO (>10 mg/ml), ethanol, DMF:PBS(pH 7.2)(1:10), and DMF. Insoluble in water. |
|---|---|
| 密度 | 1.2 |
| 敏感性 | 对热敏感 |
| 比旋光度 | -122.7° (C=0.1,CHCl3) |
| 熔点 | 203°C(lit.) |
| 分子量 | 450.600 g/mol |
| XLogP3 | 5.900 |
| 氢键供体数Hydrogen Bond Donor Count | 2 |
| 氢键受体数Hydrogen Bond Acceptor Count | 4 |
| 可旋转键计数Rotatable Bond Count | 1 |
| 精确质量Exact Mass | 450.277 Da |
| 单同位素质量Monoisotopic Mass | 450.277 Da |
| 拓扑极表面积Topological Polar Surface Area | 74.600 Ų |
| 重原子数Heavy Atom Count | 33 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 1100.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 6 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 象形图 | GHS06 |
|---|---|
| 信号词 | 危险 |
| 危险声明 |
H301: 吞咽会中毒 H303: 要是吞了可能有害 H351: 怀疑引起遗传缺陷 |
| 预防措施声明 |
P264: 处理后要彻底洗手。 P270: 使用本产品时,请勿进食、饮水或吸烟。 P321: 特殊处理(请参阅此标签上的...)。 P330: 漱口 P405: 密闭存放 P501: 将内容物/容器处理到。。。 P301+P316: 如果吞咽:立即寻求紧急医疗救助。 |
| WGK Germany | 2 |
| 个人防护装备 | Eyeshields,Faceshields,Gloves,type P2 (EN 143) respirator cartridges |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | C107672 | |
| 分析证书 | C107672 | |
| 分析证书 | C107672 | |
| 分析证书 | C107672 | |
| 分析证书 | C107672 | |
| 分析证书 | C107672 | |
| 分析证书 | C107672 | |
| 分析证书 | C107672 | |
| 分析证书 | C107672 | |
| 分析证书 | C107672 | |
| 分析证书 | C107672 | |
| 分析证书 | C107672 | |
| 分析证书 | C107672 |
| 1. Ping Sheng, Chao Bu, Tanyue Hui, Lili Zhou, Hao Chen, Guoliang Zhou. (2023) Polydopamine-activated celastrol carbon dots for synergistic chemotherapy-photothermal therapy of tumors. International Journal of Pharmaceutics-X, 6 (100218). [PMID:38033396] [10.1016/j.ijpx.2023.100218] |
| 2. Jiwen Fan, Meng Ren, Weiwei Chen, Haodong Wang, Yuquan He. (2023) Celastrol relieves myocardial infarction-induced cardiac fibrosis by inhibiting NLRP3 inflammasomes in rats. INTERNATIONAL IMMUNOPHARMACOLOGY, 121 (110511). [PMID:37343368] [10.1016/j.intimp.2023.110511] |
| 3. Xiaoli Li, Guangbei Zhu, Xintong Yao, Ning Wang, Ronghui Hu, Qingxin Kong, Duanfang Zhou, Liangyuan Long, Jiali Cai, Weiying Zhou. (2022) Celastrol induces ubiquitin-dependent degradation of mTOR in breast cancer cells. OncoTargets and Therapy, [PMID:30588010] [10.2147/OTT.S187315] |
| 4. Qiang Chen, Chunjing Guo, Zhongxin Liu, Min Cao, Wenxin Wang, Dandan Zhang, Hongxu Geng, Ningning Diao, Daquan Chen. (2023) Multifunctional nanoparticles with anti-inflammatory effect for improving metabolic syndromes. JOURNAL OF DRUG TARGETING, 31 (3): (286-295). [PMID:36315421] [10.1080/1061186X.2022.2142595] |
| 5. Bo Yu, Yiping Shen, Xuejie Zhang, Lijuan Ding, Zheng Meng, Xiaotong Wang, Meihua Han, Yifei Guo, Xiangtao Wang. (2022) Poly(methacrylate citric acid) as a Dual Functional Carrier for Tumor Therapy. Pharmaceutics, 14 (9): (1765). [PMID:36145512] [10.3390/pharmaceutics14091765] |
| 6. Lin Jingpan, Gao Lu, Lin Yanke, Wang Shuai, Yang Zemin, Ren Shujing, Chen Min, Wu Baojian. (2021) Pharmacokinetics-Based Chronoefficacy of Semen Strychni and Tripterygium Glycoside Tablet Against Rheumatoid Arthritis. Frontiers in Pharmacology, 12 [PMID:34108880] [10.3389/fphar.2021.673263] |
| 7. Niu Weina, Wang Jianguo, Wang Qinyao, Shen Jianjun. (2020) Celastrol Loaded Nanoparticles With ROS-Response and ROS-Inducer for the Treatment of Ovarian Cancer. Frontiers in Chemistry, 8 [PMID:33195064] [10.3389/fchem.2020.574614] |
| 8. Zhao Huan, Tong Yongbin, Lu Danyi, Wu Baojian. (2020) Circadian clock regulates hepatotoxicity of Tripterygium wilfordii through modulation of metabolism. JOURNAL OF PHARMACY AND PHARMACOLOGY, 72 (12): (1854-1864). [PMID:32478421] [10.1111/jphp.13299] |
| 9. Jian Lu, Daozhi Liu, Xiaojing Zhou, Ang Chen, Zhenran Jiang, Xiyun Ye, Mingyao Liu, Xin Wang. (2018) Plant natural product plumbagin presents potent inhibitory effect on human cytochrome P450 2J2 enzyme. PHYTOMEDICINE, 39 (137). [PMID:29433675] [10.1016/j.phymed.2017.12.026] |
| 10. Yang Hongbin, Liu Chang, Jiang Jie, Wang Yuena, Zhang Xiaoyu. (2017) Celastrol Attenuates Multiple Sclerosis and Optic Neuritis in an Experimental Autoimmune Encephalomyelitis Model. Frontiers in Pharmacology, 8 [PMID:28239352] [10.3389/fphar.2017.00044] |
| 11. Yunpeng Qi,Renping Wang,Liang Zhao,Lei Lv,Fan Zhou,Tian Zhang,Feng Lu,Hongli Yan,Gengli Duan. (2018-08-03) Celastrol Suppresses Tryptophan Catabolism in Human Colon Cancer Cells as Revealed by Metabolic Profiling and Targeted Metabolite Analysis.. Biological & pharmaceutical bulletin, 41 ((8)): (1243-1250). [PMID:30068874] |
| 12. Hu Yingying, Nan Yan, Lin Hongzhou, Zhao Qianlei, Chen Tingting, Tao Xiaoyue, Ding Bingqing, Lu Liying, Chen Shangqin, Zhu Jianghu, Guo Xiaoling, Lin Zhenlang. (2024) Celastrol ameliorates hypoxic-ischemic brain injury in neonatal rats by reducing oxidative stress and inflammation. PEDIATRIC RESEARCH, (1-12). [PMID:38763946] [10.1038/s41390-024-03246-9] |
| 13. Yunyan Chen, Ziwei Zhang, Zhilei Qian, Rui Ma, Minna Luan, Yu Sun. (2024) Sequentially Released Liposomes Enhance Anti-Liver Cancer Efficacy of Tetrandrine and Celastrol-Loaded Coix Seed Oil. International Journal of Nanomedicine, [PMID:38288265] [10.2147/IJN.S446895] |